I am intrigued by the use of new technology to palpate breast tissue as presented by Wellman et al1 in the ARCHIVES. Such technology may prove useful. However, I am dismayed by the present publication of unqualified statements that the tactile imaging device "can enhance cancer surveillance for patients with benign masses" and "may permit clinicians to monitor suspicious structures across time so that changes may be easily detected." The implication is that this "promising method for documenting benign breast masses" can detect a 15% change in size "as a significant difference," which will presumably lead to a biopsy when the change occurs.
Goodson WH. Concerns About Tactile Imaging and the Detection of Breast Masses. Arch Surg. 2001;136(11):1327. doi: